Cefcore S 500mg/250mg Injection
Marketer
Biocore Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefcore S 500mg/250mg Injection
Cefcore S 500mg/250mg injection is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting microbial growth, thereby curbing infection progression. Administration must be strictly under a doctor's guidance; adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation might compromise treatment efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, breathing difficulty). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Your physician may order tests to monitor the medication's effects.
Primary Ingredients of Cefcore S 500mg/250mg Injection
No text provided to rephrase.
Uses of Cefcore S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefcore S 500mg/250mg Injection:
Administering this medication will be handled by your physician or their designated nurse; patient self-administration is strictly prohibited.
Common Side effects of Cefcore S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefcore S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefcore S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefcore S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by neutralizing enzymes that bacteria use to resist antibiotic treatment, thereby improving its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Cefcore S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Cefcore S 500mg/250mg injections are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harm to the fetus; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
Administering Cefcore S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefcore S 500mg/250mg Injection may induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefcore S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefcore S (500mg/250mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage changes for Cefcore S (500mg/250mg) injection are not suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Cefcore S 500mg/250mg Injection :
Omit a Cefcore S 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Cefcore S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently